Alopecia and ocular alterations: a role for Minoxidil?

References

• Pandhi D, Singal A, Gupta R, Das G. Ocular alterations in patients of alopecia areata. J Dermatol 2009, 36, 262–268.
   PubMedGoogle Scholar
• Recupero SM, Abdolrahimzadeh S, De Dominicis M, Mollo R, Carboni I, Rota L, Calvieri S. Ocular alterations in alopecia areata. Eye (Lond) 1999, 13 (Pt 5), 643–646.
   PubMedGoogle Scholar
• Tosti A, Colombati S, Caponeri GM, Ciliberti C, Tosti G, Bosi M, Veronesi S. Ocular abnormalities occurring with alopecia areata. Dermatologica 1985, 170, 69–73.
   PubMedGoogle Scholar
• Goodyear MJ, Crewther SG, Junghans BM. A role for aquaporin-4 in fluid regulation in the inner retina. Vis Neurosci 2009, 26, 159–165.
   PubMedGoogle Scholar
• Buhl AE, Waldon DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol 1990, 95, 553–557.
   PubMed Web of Science ®Google Scholar
• Enokizono J, Kusuhara H, Sugiyama Y. Regional expression and activity of breast cancer resistance protein (Bcrp/Abcg2) in mouse intestine: overlapping distribution with sulfotransferases. Drug Metab Dispos 2007, 35, 922–928.
   PubMed Web of Science ®Google Scholar
• Halstenson CE, Opsahl JA, Wright CE, Fleishaker JC, Andreadis NA, Sobieraj J, Matzke GR. Disposition of minoxidil in patients with various degrees of renal function. J Clin Pharmacol 1989, 29, 798–802.
   PubMedGoogle Scholar
• Greene JG, Greenamyre JT. Manipulation of membrane potential modulates malonate-induced striatal excitotoxicity in vivo. J Neurochem 1996, 66, 637–643.
   PubMedGoogle Scholar
• Kiss E, Tarr T, Soltész P, Szegedi G. Crisis states in systemic lupus erythematosus. Orv Hetil 2006, 147, 2469–2473.
   PubMedGoogle Scholar
• Werner T, Brodersen HP, Janssen U. Analysis of the spectrum of nephropathies over 24 years in a West German center based on native kidney biopsies. Med Klin (Munich) 2009, 104, 753–759.
   PubMedGoogle Scholar
• Pavlovitch JH, Hubert H, Leibovitch J. Angiogenesis and minoxidil. Lancet 1990, 336, 889.
   PubMedGoogle Scholar
• Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005, 438, 960–966.
   PubMed Web of Science ®Google Scholar
• Smorlesi C, Caldarella A, Caramelli L, Di Lollo S, Moroni F. Topically applied minoxidil may cause fetal malformation: a case report. Birth Defects Res Part A Clin Mol Teratol 2003, 67, 997–1001.
   PubMed Web of Science ®Google Scholar
• Abdul M, Santo A, Hoosein N. Activity of potassium channel-blockers in breast cancer. Anticancer Res 2003, 23, 3347–3351.
   PubMed Web of Science ®Google Scholar
• Abdul M, Hoosein N. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 2002, 186, 99–105.
   PubMed Web of Science ®Google Scholar
• Abdul M, Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol Rep 2002, 9, 961–964.
   PubMed Web of Science ®Google Scholar
• Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W. Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance. Biomed Pharmacother 2010 (in press).
   Google Scholar
• Verkman AS. Aquaporins: translating bench research to human disease. J Exp Biol 2009, 212, 1707–1715.
   PubMed Web of Science ®Google Scholar
• Li J, Patil RV, Verkman AS. Mildly abnormal retinal function in transgenic mice without Müller cell aquaporin-4 water channels. Invest Ophthalmol Vis Sci 2002, 43, 573–579.
   PubMed Web of Science ®Google Scholar
• Black KL, Yin D, Konda BM, Wang X, Hu J, Ko MK, Bayan JA, Sacapano MR, Espinoza AJ, Ong JM, Irvin D, Shu Y. Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models. Brain Res 2008, 1227, 198–206.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18, 4–25.
   PubMed Web of Science ®Google Scholar
• Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13, 9–22.
   PubMed Web of Science ®Google Scholar
• Ogunshola OO, Antic A, Donoghue MJ, Fan SY, Kim H, Stewart WB, Madri JA, Ment LR. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 2002, 277, 11410–11415.
   PubMed Web of Science ®Google Scholar
• Moser KV, Humpel C. Vascular endothelial growth factor counteracts NMDA-induced cell death of adult cholinergic neurons in rat basal nucleus of Meynert. Brain Res Bull 2005, 65, 125–131.
   PubMedGoogle Scholar
• Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003, 22, 1–29.
   PubMed Web of Science ®Google Scholar
• Otomo S. Hair growth effect of minoxidil. Nippon Yakurigaku Zasshi 2002, 119, 167–174.
   PubMedGoogle Scholar
• Tian T, Fan WX, Dai YQ, Liu LP. Effect of tacrolimus on the growth cycle of murine hair follicles. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2007, 29, 209–212.
   PubMedGoogle Scholar
• Zhang L, Nothacker HP, Wang Z, Bohn LM, Civelli O. Pharmacological characterization of a selective agonist for bombesin receptor subtype-3. Biochem Biophys Res Commun 2009, 387, 283–288.
   PubMed Web of Science ®Google Scholar
• Ferrara N. VEGF as a therapeutic target in cancer. Oncology 2005, 69(Suppl 3), 11–16.
   PubMed Web of Science ®Google Scholar
• Kaplan MJ. Endothelial damage and autoimmune diseases. Autoimmunity 2009, 42, 561–562.
   PubMed Web of Science ®Google Scholar
• Sandhiya S, Dkhar SA. Potassium channels in health, disease & development of channel modulators. Indian J Med Res 2009, 129, 223–232.
   PubMedGoogle Scholar
• Bosco A, Cusato K, Nicchia GP, Frigeri A, Spray DC. A developmental switch in the expression of aquaporin-4 and Kir4.1 from horizontal to Müller cells in mouse retina. Invest Ophthalmol Vis Sci 2005, 46, 3869–3875.
   PubMedGoogle Scholar
• Bringmann A, Reichenbach A, Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res 2004, 36, 241–249.
   PubMed Web of Science ®Google Scholar
• Shorter K, Farjo NP, Picksley SM, Randall VA. Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J 2008, 22, 1725–1736.
   PubMed Web of Science ®Google Scholar
• Puro DG, Yuan JP, Sucher NJ. Activation of NMDA receptor-channels in human retinal Müller glial cells inhibits inward-rectifying potassium currents. Vis Neurosci 1996, 13, 319–326.
   PubMedGoogle Scholar
• Budni J, Gadotti VM, Kaster MP, Santos AR, Rodrigues AL. Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test. Eur J Pharmacol 2007, 575, 87–93.
   PubMedGoogle Scholar
• Harkany T, Grosche J, Mulder J, Horvath KM, Keijser J, Hortobágyi T, Luiten PG, Härtig W. Short-term consequences of N-methyl-D-aspartate excitotoxicity in rat magnocellular nucleus basalis: effects on in vivo labelling of cholinergic neurons. Neuroscience 2001, 108, 611–627.
   PubMedGoogle Scholar
• Gunnarson E, Zelenina M, Axehult G, Song Y, Bondar A, Krieger P, Brismar H, Zelenin S, Aperia A. Identification of a molecular target for glutamate regulation of astrocyte water permeability. Glia 2008, 56, 587–596.
   PubMed Web of Science ®Google Scholar
• Guran T, Bircan R, Turan S, Bereket A. Alopecia: association with resistance to thyroid hormones. J Pediatr Endocrinol Metab 2009, 22, 1075–1081.
   PubMedGoogle Scholar
• Betz RC, Pforr J, Flaquer A, Redler S, Hanneken S, Eigelshoven S, Kortüm AK, Tüting T, Lambert J, De Weert J, Hillmer AM, Schmael C, Wienker TF, Kruse R, Lutz G, Blaumeiser B, Nöthen MM. Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol 2007, 127, 2539–2543.
   PubMedGoogle Scholar
• Bradl M, Lassmann DH. Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance? Int MS J 2008, 15, 75–78.
   PubMedGoogle Scholar
• Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009, 66, 630–643.
   PubMed Web of Science ®Google Scholar
• Kira J. Recent advances of multiple sclerosis research in Japan. Rinsho Shinkeigaku 2009, 49, 549–559.
   PubMedGoogle Scholar
• Li L, Zhang H, Verkman AS. Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice. BMC Neurosci 2009, 10, 94.
   PubMedGoogle Scholar
• Wolburg-Buchholz K, Mack AF, Steiner E, Pfeiffer F, Engelhardt B, Wolburg H. Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis. Acta Neuropathol 2009, 118, 219–233.
   PubMed Web of Science ®Google Scholar
• Kanbayashi T, Shimohata T, Nakashima I, Yaguchi H, Yabe I, Nishizawa M, Shimizu T, Nishino S. Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch Neurol 2009, 66, 1563–1566.
   PubMedGoogle Scholar
• Schwartz GL, Turner ST. Pharmacogenetics of antihypertensive drug responses. Am J Pharmacogenomics 2004, 4, 151–160.
   PubMedGoogle Scholar
• Jones AL, Hagen M, Coughtrie MW, Roberts RC, Glatt H. Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. Biochem Biophys Res Commun 1995, 208, 855–862.
   PubMed Web of Science ®Google Scholar
• Raftogianis RB, Her C, Weinshilboum RM. Human phenol sulfotransferase pharmacogenetics: STP1 gene cloning and structural characterization. Pharmacogenetics 1996, 6, 473–487.
   PubMedGoogle Scholar
• Ebmeier CC, Anderson RJ. Human thyroid phenol sulfotransferase enzymes 1A1 and 1A3: activities in normal and diseased thyroid glands, and inhibition by thyroid hormones and phytoestrogens. J Clin Endocrinol Metab 2004, 89, 5597–5605.
   PubMed Web of Science ®Google Scholar
• Xiao F, Pardue S, Arnold TC, Monroe J, Alexander JS, Carden DL, Turnage R, Conrad SA. Ifenprodil treatment is associated with a down-regulation of brain aquaporin 4 following cardiac arrest in rats. Acta Neurochir Suppl 2005, 95, 415–419.
   PubMedGoogle Scholar